Venus Concept News

Analysts Offer Insights on Healthcare Companies: High Tide (HITI), Venus Concept (VERO) and Immunocore Holdings (IMCR)

TipRanksApr 3 07:40 ET

BTIG Keeps Their Hold Rating on Venus Concept (VERO)

TipRanksFeb 2 07:28 ET

BTIG Remains a Hold on Venus Concept (VERO)

TipRanksJan 7 05:49 ET

Analysts Conflicted on These Healthcare Names: Staar Surgical (STAA), Venus Concept (VERO) and Eli Lilly & Co (LLY)

TipRanksJan 2 09:51 ET

BTIG Keeps Their Hold Rating on Venus Concept (VERO)

TipRanksDec 31, 2023 05:28 ET

Venus Concept Analyst Ratings

BenzingaOct 6, 2023 07:46 ET

Venus Concept (VERO) Gets a Hold From Maxim Group

TipRanksMay 16, 2023 15:45 ET

Analysts Are Bullish on Top Healthcare Stocks: Venus Concept (VERO), Disc Medicine (IRON)

TipRanksMay 15, 2023 11:20 ET

Ladenburg Thalmann Maintains Buy on Venus Concept, Lowers Price Target to $2.2

BenzingaMar 28, 2023 10:17 ET

Maxim Group Sticks to Their Buy Rating for Venus Concept (VERO)

TipRanksFeb 8, 2023 15:36 ET

BTIG Remains a Buy on Venus Concept (VERO)

TipRanksFeb 7, 2023 08:26 ET

Venus Concept (VERO) Receives a Buy From Maxim Group

TipRanksNov 12, 2022 08:05 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Nabriva (NBRV) and Venus Concept (VERO)

TipRanksNov 11, 2022 09:40 ET

Maxim Group Sticks to Its Buy Rating for Venus Concept (VERO)

TipRanksOct 5, 2022 07:45 ET

BTIG Sticks to Their Buy Rating for Venus Concept (VERO)

TipRanksOct 3, 2022 09:45 ET

Venus Concept (VERO) Gets a Buy from Maxim Group

TipRanksAug 13, 2022 16:05 ET

Analysts Offer Insights on Healthcare Companies: Venus Concept (VERO) and Leap Therapeutics (LPTX)

TipRanksAug 12, 2022 12:15 ET

Venus Concept Price Target Cut to $5.50/Share From $7.00 by BTIG

Dow JonesJun 24, 2022 10:29 ET

Venus Concept Is Maintained at Buy by BTIG

Dow JonesJun 24, 2022 10:29 ET

BTIG Research Adjusts Venus Concept Price Target to $5.50 From $7, Maintains Buy Rating

MT NewswiresJun 24, 2022 10:21 ET